| Irritable Bowel Syndrome |
1 |
1 |
| Biologic Therapy |
0 |
0.95 |
| Clostridium Difficile Infection |
0 |
0.9 |
| Microbiome |
0 |
1 |
| Fecal Transplant |
0 |
0.75 |
| Small Intestine |
0 |
0.99 |
| Large Intestine |
0 |
0.98 |
| Bacteria |
0 |
0.33 |
| Transplantation |
0 |
0.3 |
| Pain Management |
0 |
0.17 |
| Abdominal Pain |
0 |
0.14 |
| Fatigue |
0 |
0.14 |
| Quality of Life |
0 |
0.14 |
| Diarrhea |
0 |
0.09 |
| Abdomen |
0 |
0.08 |
| Pain |
0 |
0.08 |
| Constipation |
0 |
0.07 |
| Inflammatory Bowel Disease |
0 |
0.07 |
| Patient Safety |
0 |
0.07 |
| Adverse Effects |
0 |
0.06 |
| Pharmacokinetics |
0 |
0.06 |
| Psoriatic Arthritis |
0 |
0.05 |
| Ulcerative Colitis |
0 |
0.05 |
| Antibiotics |
0 |
0.03 |
| Arthritis |
0 |
0.03 |
| Bile |
0 |
0.03 |
| Bowel Preparation |
0 |
0.03 |
| Colitis |
0 |
0.03 |
| Colonoscopy |
0 |
0.03 |
| Drug Interaction |
0 |
0.03 |
| Dyspepsia |
0 |
0.03 |
| Europe |
0 |
0.03 |
| Gastroesophageal Reflux Disease |
0 |
0.03 |
| Minnesota |
0 |
0.03 |
| Nutrition |
0 |
0.03 |
| Pharmacodynamics |
0 |
0.03 |
| Toxicology |
0 |
0.03 |